New York Times Co vs Zimmer Biomet Holdings Inc — how do they compare? New York Times Co trades at $72.89 (market cap $12.09B), while Zimmer Biomet Holdings Inc trades at $88.69 (market cap $17.20B). The key difference: Zimmer Biomet Holdings Inc is the larger of the two by market cap, and New York Times Co pays the higher dividend (1.23%). Which is the better fit depends on your goals.
| NYT | ZBH | |
|---|---|---|
Market Cap | $12.09B | $17.20B |
Sector | Media | Health |
52-Week High | $85.86 | $107.71 |
52-Week Low | $51.43 | $79.58 |
Enterprise Value | $11.48B | $24.25B |
Dividend Yield | 1.23% | 1.08% |
Trailing returns across standard periods
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →